Effects of single administration of a phosphodiesterase III inhibitor during cardiopulmonary bypass - Comparison of milrinone and amrinone

Japanese Circulation Journal

Volumn 63, Issue 8, 1999, Pages 605-609

  Hamada, Yoshihiro ^a   Kawachi, Kanji ^a   Yamamoto, Tetsuya ^a   Nakata, Tatsuhiro ^a   Kashu, Yasuaki ^a   Sato, Motomichi ^a   Watanabe, Yuji ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Amrinone; Cardiac surgery; Cardiopulmonary bypass; Milrinone; Phosphodiesterase III inhibitors

Indexed keywords

AMRINONE; CATECHOLAMINE; MILRINONE; PHOSPHODIESTERASE INHIBITOR;

ADULT; AGED; AORTA CLAMPING; AORTA PRESSURE; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; FEMALE; HEART INDEX; HEART RATE; HEART VALVE REPLACEMENT; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG ARTERY PRESSURE; LUNG CAPILLARY PRESSURE; MALE; OPEN HEART SURGERY; PERFUSION PRESSURE; SYSTEMIC VASCULAR RESISTANCE; WARMING;

EID: 0032776794     PISSN: 00471828     EISSN: None     Source Type: Journal    
DOI: 10.1253/jcj.63.605     Document Type: Article

References (21)

1. Endo M, Yamashita S, Taira N: Positive inotropic effect of amrinone in relation to cyclic nucleotide metabolism in the canine ventricular muscle. J Pharmacol Exp Ther 1982; 221: 775-783
2. Endo M, Yanagisawa T, Taira N, Blinks CR: Effects of new inotropic agents on cyclic nucleotide metabolism and calcium transients in canine ventricular muscle. Circulation 1986; 73(Suppl III): III-117-III-133
3. Anderson JL: Hemodynamic and clinical benefits with intravenous milrinone in severe chronic heart failure: Results of a multicenter study in the United States. Am Heart J 1991; 121: 1956-1964
4. Goenen M, Pedemonte O, Baele P, Col J: Amrinone in the management of low cardiac output after open heart surgery. Am J Cardiol 1985; 56: 33B-38B
5. De Hert S, Moens MM, Jorens PG, Delrue GL, De Paep RJ, Vermeyen KM: Comparison of two different loading doses of milrinone for weaning from cardiopulmonary bypass. J Cardiothorac Vasc Anesth 1995; 9: 264-271
6. Doolan LA, Jones EF, Kalman J, Buxton B, Tonkin M: A placebo-controlled trial verifying the efficacy of milrinone in weaning high-risk patients from cardiopulmonary bypass. J Cardiothorac Vasc Anesth 1997; 11: 37-41
7. Alousi AA, Stankus GP, Stuart JC, Walton LH: Characterization of the cardiotonic effects of milrinone, a new and potent cardiac bypyridine, on isolated tissues from several animal species. J Cardiovasc Pharmacol 1983; 5: 804-811
8. Calafiore AM, Angelini GD, Bergsland J, Salerno TA: Minimally invasive coronary artery bypass grafting. Ann Thorac Surg 1996; 62: 1545-1548
9. Monrad ES, Donald SB, Smith HS, Lanoue A, Braunwald E, Grossman W: Effects of milrinone on coronary hemodynamics and myocardial energetics in patients with congestive heart failure. Circulation 1985; 75: 972-979
10. Jentzer JH, Lejemtel TH, Sonnenblick EF, Kirk ES: Beneficial effect of amrinone on myocardial oxygen consumption during acute left ventricular failure in dogs. Am J Cardiol 1981; 48: 75-83
11. Monrad ES, Baim DS, Smith HS, Lanoue AS: Milrinone, dobutamine, and nitroprusside: comparative effects on hemodynamics and myocardial energetics in patients with severe congestive heart failure. Circulation 1986; 73(Suppl III): III-168-III-174
12. Feneck RO: Intravenous milrinone following cardiac surgery. I. Effects of bolus infusion followed by variable dose maintenance infusion. J Cardiothorac Vasc Anesth 1992; 6: 554-562
13. Feneck RO: Intravenous milrinone following cardiac surgery. II. Influence of baseline hemodynamics and patient factors on therapeutic response. J Cardiothorac Vasc Anesth 1992; 6: 563-567
14. Das PA, Skoyles JR, Sherry KM, Peacock JE, Fox PA, Woolfrey SG. Disposition of milrinone in patients after cardiac surgery. Br J Anaesth 1994; 72: 426-429
15. Chang AC, Atz AM, Wernovsky G, Burke RP, Wessel DL: Milrinone: Systemic and pulmonary hemodynamic effects in neonates after cardiac surgery. Crit Care Med 1995; 23: 1907-1914
16. Butterworth JF IV, Hines RL, Royster RL, James RL: A pharmacokinetic and pharmacodynamic evaluation of milrinone in adults undergoing cardiac surgery. Anesth Analg 1995; 81: 783-792
17. Kikura M, Levy JH, Michelsen LG, Shanewise JS, Bailey JM, Sadel SM, et al: The effects of milrinone on hemodynamics and left ventricular function after emergence from cardiopulmonary bypass. Anesth Analg 1997; 85: 16-22
18. Bailey JM, Levy JH, Rogers HG, Sziam F, Hug CC Jr: Pharmacokinetics of amrinone during cardiac surgery. Anesthesiology 1991; 75: 961-968
19. Benotti JR, Lesko LJ, McCue JE, Alpert JS: Pharmacokinetics and pharmacodynamics of milrinone in chronic congestive heart failure. Am J Cardiol 1985; 56: 685-689
20. Kullberg MP, Freeman GB, Biddlecome C, Alousi AA, Edelson J: Amrinone metabolism. Clin Pharmacol Ther 1981; 29: 394-401
21. Goldstein RA: Clinical effects of intravenous amrinone in patients with congestive heart failure. Circulation 1986; 73(Suppl III): III-191-III-195